Therapeutic advances in 5q-linked spinal muscular atrophy
ABSTRACT Spinal muscular atrophy (SMA) is a severe and clinically-heterogeneous motor neuron disease caused, in most cases, by a homozygous mutation in the SMN1 gene. Regarding the age of onset and motor involvement, at least four distinct clinical phenotypes have been recognized. This clinical vari...
Saved in:
| Main Authors: | Umbertina Conti Reed, Edmar Zanoteli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000400265&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy
by: Edmar Zanoteli, et al.
Published: (2024-01-01) -
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies
by: Brenda Klemm Arci Mattos de Freitas Alves, et al.
Published: (2024-11-01) -
Atrofia muscular progressiva: estudo clínico e laboratorial em onze pacientes
by: Maria Elisabeth Matta de Rezende Ferraz, et al.
Published: (2004-03-01) -
Dificuldades diagnósticas na atrofia muscular espinhal Spinal muscular atrophy diagnostic difficulties
by: Alexandra Prufer de Q-C. Araújo, et al.
Published: (2005-03-01) -
A self-reported Brazilian registry of 5q-spinal muscular atrophy: data on natural history, genetic characteristics, and multidisciplinary care
by: Rodrigo Holanda Mendonça, et al.
Published: (2024-12-01)